Cytosolv

Biotech company developing encapsulating cell technology for indications in cell therapy; acquired by Semma Therapeutics in 2015

placeNewport, Rhode Island, United States calendar_todayFounded 2009 groups8 employees language cytosolv.com

Innovation

1 patent family — focus: Human necessities; filing pace dormant. Cited 5 times.

YearFilings
20181

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon